11:46 AM EDT, 05/12/2025 (MT Newswires) -- Horizon Space Acquisition II ( HSPT ) agreed to merge with SL Bio, which is developing cellular and gene therapies for cancer treatment.

The combined entity will be listed on the Nasdaq, and shareholders of Horizon Space Acquisition and SL Bio will get shares in the newly formed company.

The transaction was approved by both boards and is expected to close late this year, the companies said Monday in a statement.

The new company will be led by SL Bio Chief Executive Officer William Wang.